Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

Quattrin, Teresa; J. Haller, Michael; K. Steck, Andrea; I. Felner, Eric; Li, Yinglei; Xia, Yichuan; H. Leu, Jocelyn; Zoka, Ramineh; A. Hedrick, Joseph; Rigby, Mark; Vercruysse, Frank

doi:10.1056/nejmoa2006136

Public

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

Published in New England Journal of Medicine • Nov 18, 2020

Authors:

Teresa Quattrin

Michael J. Haller

Andrea K. Steck

Abstract

BACKGROUND: that has already been approved for the treatment of several autoimmune conditions in adults and children. Whether golimumab could preserve beta-cell function in youth with newly diagnosed overt (stage 3) type 1 diabetes is unknown. METHODS: In this phase 2, multicenter, placebo-controlle...

Subject

Golimumab

Type 2 diabetes

BETA (programming language)

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!